Rights and permissions
About this article
Cite this article
Dose-optimisation intervention produces cost savings in the US. Pharmacoecon. Outcomes News 364, 5 (2002). https://doi.org/10.1007/BF03279109
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03279109